This content is restricted.
Brief
An inspection at Theramex France's establishment in Neuilly-sur-Seine revealed significant non-conformities and shortcomings. The French National Agency for Medicines and Health Products Safety (ANSM) issued a notice to correct these issues, including lacunes in information medical management, insuffisances in advertising management, carences in pharmacovigilance management, and more. Compliance actions were ordered to be implemented within specific deadlines, with failure to comply potentially affecting Theramex France's operations and reputation.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested